In another study, in contrast, msbA had a highly significant p value in the tigecycline-resistant group; they considered msbA mutations to be gain-of-function mutations and speculated that a possible resistance mechanism is that these mutations expand pump specificity, facilitating tigecycline efflux ( Hammerstrom et al., 2015 ).
1
—
—